Upon phagocytosis of dying cancer cells, DCs fulfil their primary role by processing and presenting tumor Ags to CD4+ T helper cells, while some subsets of DCs possess the capability to cross-present tumor Ags to CD8+ T cells, and thus stimulate the effector cells of the antitumor response9. The gene discussed is CD8A; the disease is neoplasm.